Diagnostic intervals and imaging use in lung cancer: a national real-world study in England.

Monica L Mullin¹, Xiaocong Li Marston², Hannah Matthews², James Lavin³, Ricky Thakrar⁴

¹Department of Respirology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

²Evidence and Access, OPEN Health Communications LLP London, London, England, UK.

³HEOR, Intuitive Surgical Sàrl, Aubonne, Switzerland James.lavin@intusurg.com.

⁴University College London Hospitals NHS Foundation Trust, London, England, UK.

PubMed DOI

Abstract

BACKGROUND: Timely diagnosis is critical for improving lung cancer outcomes, yet diagnostic pathways in England remain complex and variable. Real-world evidence examining imaging use, delays and emergency care during the diagnostic interval is limited. METHODS: We conducted a national retrospective cohort study using linked Hospital Episode Statistics and Diagnostic Imaging Dataset for adults new…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.